HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4+ T cells and macrophages

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3651-3662

  Lombardelli, Letizia ^a   Aguerre Girr, Maryse ^b   Logiodice, Federica ^a   Kullolli, Ornela ^a   Casart, Ysabel ^b   Polgar, Beata ^b,d   Berrebi, Alain ^b,c   Romagnani, Sergio ^a   Maggi, Enrico ^a   Le Bouteiller, Philippe ^b   Piccinni, Marie Pierre ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CHU PURPAN   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; HLA G ANTIGEN; HLA G5 ANTIGEN; ILT2 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TROPHOBLAST;

ADULT; ANTIGENS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE EXPRESSION REGULATION; HLA-G ANTIGENS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MODELS, IMMUNOLOGICAL; PREGNANCY; RECEPTORS, IMMUNOLOGIC; TETANUS TOXIN; TROPHOBLASTS;

EID: 84885126166     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300567     Document Type: Article

References (62)

1. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2:656-663.
2. Tilburgs, T., S. A. Scherjon, B. J. van der Mast, G. W. Haasnoot, M. Versteeg-V D Voort-Maarschalk, D. L. Roelen, J. J. van Rood, and F. H. Claas. 2009. Fetalmaternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 82:148-157.
3. Wegmann, T. G., H. Lin, L. Guilbert, and T. R. Mosmann. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14:353-356.
4. Lin, H., T. R. Mosmann, L. Guilbert, S. Tuntipopipat, and T. G. Wegmann. 1993. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151:4562-4573.
5. Piccinni, M. P., and S. Romagnani. 1996. Regulation of fetal allograft survival by a hormone-controlled Th1-and Th2-type cytokines. Immunol. Res. 15:141-150.
6. Piccinni, M. P., L. Beloni, C. Livi, E. Maggi, G. Scarselli, and S. Romagnani. 1998. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 4:1020-1024.
7. Piccinni, M. P., C. Scaletti, A. Vultaggio, E. Maggi, and S. Romagnani. 2001. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J. Reprod. Immunol. 52:35-43.
8. Piccinni, M. P. 2010. T cell tolerance towards the fetal allograft. J. Reprod. Immunol. 85:71-75.
9. Saito, S., N. Tsukaguchi, T. Hasegawa, T. Michimata, H. Tsuda, and N. Narita. 1999. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am. J. Reprod. Immunol. 42:240-245.
10. Michimata, T., M. Sakai, S. Miyazaki, M. S. Ogasawara, K. Suzumori, K. Aoki, K. Nagata, and S. Saito. 2003. Decrease of T-helper 2 and T-cytotoxic 2 cells at implantation sites occurs in unexplained recurrent spontaneous abortion with normal chromosomal content. Hum. Reprod. 18:1523-1528.
11. Graca, L., S. P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195:1641-1646.
12. Piccinni, M. P., M. G. Giudizi, R. Biagiotti, L. Beloni, L. Giannarini, S. Sampognaro, P. Parronchi, R. Manetti, F. Annunziato, C. Livi, et al. 1995. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155:128-133.
13. Hunt, J. S., and D. L. Langat. 2009. HLA-G: a human pregnancy-related immunomodulator. Curr. Opin. Pharmacol. 9:462-469.
14. Carosella, E. D., B. Favier, N. Rouas-Freiss, P. Moreau, and J. Lemaoult. 2008. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111:4862-4870.
15. Apps, R., L. Gardner, and A. Moffett. 2008. A critical look at HLA-G. Trends Immunol. 29:313-321.
16. Shiroishi, M., K. Kuroki, T. Ose, L. Rasubala, I. Shiratori, H. Arase, K. Tsumoto, I. Kumagai, D. Kohda, and K. Maenaka. 2006. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 281:10439-10447.
17. Solier, C., M. Aguerre-Girr, F. Lenfant, A. Campan, A. Berrebi, V. Rebmann, H. Grosse-Wilde, and P. Le Bouteiller. 2002. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur. J. Immunol. 32:3576-3586.
18. Morales, P. J., J. L. Pace, J. S. Platt, T. A. Phillips, K. Morgan, A. T. Fazleabas, and J. S. Hunt. 2003. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J. Immunol. 171:6215-6224.
19. Ishitani, A., N. Sageshima, N. Lee, N. Dorofeeva, K. Hatake, H. Marquardt, and D. E. Geraghty. 2003. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 171:1376-1384.
20. Morales, P. J., J. L. Pace, J. S. Platt, D. K. Langat, and J. S. Hunt. 2007. Synthesis of beta (2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 122:179-188.
21. Apps, R., L. Gardner, A. M. Sharkey, N. Holmes, and A. Moffett. 2007. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigenpresenting cells via LILRB1. Eur. J. Immunol. 37:1924-1937.
22. Li, C., B. L. Houser, M. L. Nicotra, and J. L. Strominger. 2009. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc. Natl. Acad. Sci. USA 106:5767-5772.
23. Gonen-Gross, T., H. Achdout, T. I. Arnon, R. Gazit, N. Stern, V. Horejsí, D. Goldman-Wohl, S. Yagel, and O. Mandelboim. 2005. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J. Immunol. 175:4866-4874.
24. Shiroishi, M., K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V. M. Braud, D. S. Allan, A. Makadzange, S. Rowland-Jones, B. Willcox, et al. 2003. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100:8856-8861.
25. Ellis, S. A., I. L. Sargent, C. W. Redman, and A. J. McMichael. 1986. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 59:595-601.
26. Kovats, S., E. K. Main, C. Librach, M. Stubblebine, S. J. Fisher, and R. De Mars. 1990. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220-223.
27. Carosella, E. D. 2000. [HLA-G: fetomaternal tolerance]. C. R. Acad. Sci. III 323:675-680.
28. Le Bouteiller, P., and I. L. Sargent. 2000. HLA class I molecules in the placenta: which ones, where and what for? A workshop report. Placenta 21(Suppl A):S93-S96.
29. Ober, C., and C. L. Aldrich. 1997. HLA-G polymorphisms: neutral evolution or novel function? J. Reprod. Immunol. 36:1-21.
30. King, A., T. D. Burrows, S. E. Hiby, J. M. Bowen, S. Joseph, S. Verma, P. B. Lim, L. Gardner, P. Le Bouteiller, A. Ziegler, et al. 2000. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 21:376-387.
31. Hunt, J. S., D. K. Langat, R. H. McIntire, and P. J. Morales. 2006. The role of HLA-G in human pregnancy. Reprod. Biol. Endocrinol. 4(Suppl 1):S10.
32. Fournel, S., M. Aguerre-Girr, A. Campan, L. Salauze, A. Berrebi, Y. C. Lone, F. Lenfant, and P. Le Bouteiller. 1999. Soluble HLA-G: purification from eukaryotic transfected cells and detection by a specific ELISA. Am. J. Reprod. Immunol. 42:22-29.
33. Fons, P., S. Chabot, J. E. Cartwright, F. Lenfant, F. L'Faqihi, J. Giustiniani, J. P. Herault, G. Gueguen, F. Bono, P. Savi, et al. 2006. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108:2608-2615.
34. Piccinni, M. P., D. Bani, L. Beloni, C. Manuelli, C. Mavilia, F. Vocioni, M. Bigazzi, T. B. Sacchi, S. Romagnani, and E. Maggi. 1999. Relaxin favors the development of activated human T cells into Th1-like effectors. Eur. J. Immunol. 29:2241-2247.
35. El Costa, H., A. Casemayou, M. Aguerre-Girr, M. Rabot, A. Berrebi, O. Parant, M. Clouet-Delannoy, L. Lombardelli, N. Jabrane-Ferrat, D. Rukavina, et al. 2008. Critical and differential roles of NKp46-and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J. Immunol. 181:3009-3017.
36. Barakonyi, A., K. T. Kovacs, E. Miko, L. Szereday, P. Varga, and J. Szekeres-Bartho. 2002. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy. J. Immunol. 168:2683-2688.
37. Pröll, J., A. Bensussan, F. Goffin, J. M. Foidart, A. Berrebi, and P. Le Bouteiller. 2000. Tubal versus uterine placentation: similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 56:479-491.
38. Bustin, S. A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:169-193.
39. Maecker, H. T., and J. Trotter. 2006. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037-1042.
40. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-1204.
41. Maggi, E., P. Parronchi, R. Manetti, C. Simonelli, M. P. Piccinni, F. S. Rugiu, M. De Carli, M. Ricci, and S. Romagnani. 1992. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148:2142-2147.
42. Bulmer, J. N., P. J. Williams, and G. E. Lash. 2010. Immune cells in the placental bed. Int. J. Dev. Biol. 54:281-294.
43. Allhorn, S., C. Böing, A. A. Koch, R. Kimmig, and I. Gashaw. 2008. TLR3 and TLR4 expression in healthy and diseased human endometrium. Reprod. Biol. Endocrinol. 6:40.
44. Kanai, T., T. Fujii, S. Kozuma, T. Yamashita, T. Miki, A. Kikuchi, and Y. Taketani. 2001. Soluble HLA-G influences the release of cytokine from allogenic peripheral blood mononuclear cells in colture. Mol. Hum. Reprod. 7:195-200.
45. Kanai, T., T. Fujii, S. Kozuma, A. Miki, T. Yamashita, H. Hyodo, N. Unno, S. Yoshida, and Y. Taketani. 2003. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1. J. Reprod. Immunol. 60:85-96.
46. Tahan, F., and T. Patiroglu. 2006. Plasma soluble human leukocyte antigen G levels in asthmatic children. Int. Arch. Allergy Immunol. 141:213-216.
47. Ciprandi, G., B. M. Colombo, P. Contini, P. Cagnati, A. Pistorio, F. Puppo, and G. Murdaca. 2008. Soluble HLA-G and HLA-A, -B, -C serum levels in patients with allergic rhinitis. Allergy 63:1335-1338.
48. Romagnani, S. 1994. Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immunol. 6:838-846.
49. Ciprandi, G., P. Contini, A. Pistorio, G. Murdaca, and F. Puppo. 2009. Sublingual immunotherapy reduces soluble HLA-G and HLA-A, -B, -C serum levels in patients with allergic rhinitis. Int. Immunopharmacol. 9:253-257.
50. Rajagopalan, S., and E. O. Long. 2012. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol 3:258.
51. Xu, X., Q. Fu, Q. Zhang, M. Zhao, Z. Gao, X. Liu, Y. Liu, and X. Hu. 2013. Changes of human decidual natural killer cells cocultured with YFP-Toxoplasma gondii: implications for abnormal pregnancy. Fertil. Steril. 99:427-432.
52. Miyazaki, S., H. Tsuda, M. Sakai, S. Hori, Y. Sasaki, T. Futatani, T. Miyawaki, and S. Saito. 2003. Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J. Leukoc. Biol. 74:514-522.
53. Cecati, M., S. R. Giannubilo, M. Emanuelli, A. L. Tranquilli, and F. Saccucci. 2011. HLA-G and pregnancy adverse outcomes. Med. Hypotheses 76:782-784.
54. Dahl, M., and T. V. Hviid. 2012. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum. Reprod. Update 18:92-109.
55. Kolte, A. M., R. Steffensen, H. S. Nielsen, T. V. Hviid, and O. B. Christiansen. 2010. Study of the structure and impact of human leukocyte antigen (HLA)-G-A, HLA-G-B, and HLA-G-DRB1 haplotypes in families with recurrent miscarriage. Hum. Immunol. 71:482-488.
56. Loisel, D. A., C. Billstrand, K. Murray, K. Patterson, T. Chaiworaphongsa, R. Romero, and C. Ober. 2013. The maternal HLA-G 1597ΔC null mutation is associated with increased risk of preeclampsia and reduced HLA-G expression during pregnancy in African American women. Mol. Hum. Reprod. 19:144-152.
57. Yie, S. M., L. H. Li, Y. M. Li, and C. Librach. 2004. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am. J. Obstet. Gynecol. 191:525-529.
58. Hara, N., T. Fujii, T. Yamashita, S. Kozuma, T. Okai, and Y. Taketani. 1996. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody "CAM5.2". Am. J. Reprod. Immunol. 36:349-358.
59. Goldman-Wohl, D. S., I. Ariel, C. Greenfield, D. Hochner-Celnikier, J. Cross, S. Fisher, and S. Yagel. 2000. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol. Human Reprod. 6:88-95.
60. Rizzo, R., A. S. Andersen, M. R. Lassen, H. C. Sørensen, T. Bergholt, M. H. Larsen, L. Melchiorri, M. Stignani, O. R. Baricordi, and T. V. Hviid. 2009. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am. J. Reprod. Immunol. 62:320-338.
61. Emmer, P. M., I. Joosten, M. H. Schut, P. L. Zusterzeel, J. C. Hendriks, and E. A. Steegers. 2004. Shift in expression of HLA-G mRNA spliceforms in pregnancies complicated by preeclampsia. J. Soc. Gynecol. Investig. 11:220-226.
62. Jin, L. P., Y. H. Zhou, X. Y. Zhu, M. Y. Wang, and D. J. Li. 2006. Adoptive transfer of paternal antigen-hyporesponsive T cells facilitates a Th2 bias in peripheral lymphocytes and at materno-fetal interface in murine abortion-prone matings. Am. J. Reprod. Immunol. 56:258-266.